Mouse liver contains two NK cell populations, one of which recirculates while the other is tissue-resident. Following this discovery, a number of groups have sought to identify liverresident NK cells in humans. This essay presents an overview of recent advances in the field.
The Hunt for lrNK in Humans
In the light of these findings, a number of groups attempted to define lrNK in humans. CD49a is considered the definitive cell surface marker for lrNK in mice, so the first such attempt examined the expression of CD49a by human liver NK cells [5] . A small CD49a + NK cell population was found in the parenchyma and these cells are absent in peripheral, portal venous or hepatic venous blood, suggesting they are liver-resident.
NK cells in human blood are divided into CD56 bright and CD56 dim subsets, where the majority are CD56 dim . Human liver is enriched in CD56 bright NK cells and these express CD69, which is now recognised as a marker not only of activation but also of tissue residence. Therefore, the next attempt at defining lrNK in humans focussed on CD56 bright NK cells, finding that they express a distinctive panel of chemokine receptors, integrins and L-selectin, which is likely to mediate their retention in the liver [6] . Like mouse lrNK, they are located primarily in the sinusoids and are likely to be retained there by the interaction of CCR5 and CXCR6, expressed by the NK cells, and their ligands on sinusoidal endothelial cells [6] . Indeed, another recent study has suggested that human lrNK should be defined not as CD56 bright but as CXCR6 + , similar to mouse lrNK [7] .
Neither CD56 nor CXCR6 expression define liver-residence, since significant CD56 bright and CXCR6 + populations are present in blood [6, 7] . A consensus is now emerging that the best way to distinguish between cNK and lrNK in humans is by their expression of Tbet and Eomes [7] [8] [9] . Eomes hi Tbet lo NK cells (henceforth "Eomes hi ") account for some 50% of human liver NK cells, but are completely absent in blood, and largely, but not completely, overlap with the CD56 bright and CXCR6 + populations. However, the Eomes hi population does not overlap with the CD49a + population [5, 7] . It seems, then, that there are two non-overlapping NK cell populations that are potentially liver-resident in humans: CD49a + NK cells and Eomes hi (largely CD56 bright and CXCR6 + ) NK cells.
The absence of Eomes hi NK cells in blood, together with their expression of proteins associated with tissue retention, points to these cells representing lrNK, but is not definitive. Recently, however, we have been able to carry out experiments in humans roughly equivalent to the parabiosis experiments that defined lrNK in mice. In clinical liver transplantation, donors and recipients are not routinely HLA-matched, allowing recipientderived cells to be distinguished from those originating from the donor liver by their expression of HLA variants. Taking this approach, we showed that Eomes hi NK cells cannot exit the liver and are long-lived in the liver for up to 13 years, whereas Eomes lo cNK cells recirculate freely [9] . This allows us to say with some certainty that Eomes hi NK cells are indeed liver-resident in humans.
While performing these experiments, we made the unexpected observation that recipientderived Eomes hi lrNK emerge within weeks of transplantation, indicating replenishment from the circulation. We further found that, on culture with cytokines that are highly expressed in the liver, sorted Eomes lo cNK upregulate Eomes together with cell surface markers associated with an lrNK phenotype [9] . This was surprising because, in mice, cNK and lrNK are thought to form separate lineages [2] . It is, of course, possible that human and mouse lrNK differ in this respect but it is worth noting a small degree of flexibility between the two lineages in mice, even in the most stringent experiments [2, 3] . It is also possible that the immunosuppression to which transplant patients are subjected alters the ability of circulating cells to be recruited to the liver and fill a resident niche. There is some evidence that this is the case for Kupffer cells [10] and it has been suggested that the conflicting outcomes of adoptive transfers reported by Gordon and Daussy could be a result of different conditioning regimes in the recipient mice.
Future Directions
In both mice and humans, lrNK cells are present and something of their origin and lineage is now understood. However, the function of these cells remains obscure. Since studies in humans have been informed by those in mice, experiments in mice are likely to be a necessary first step in defining the functions of lrNK in humans. Mouse lrNK may be "memory" cells [3] and CD49a + lrNK in humans are NKG2C + , reminiscent of NKG2C + NK cells in the blood, which may have memory of HCMV [5] . Meanwhile, the longevity of the Eomes hi lrNK population could also be suggestive of memory [9] . Experiments to test the idea that either population represents memory cells will be challenging to perform in humans, although bulk hepatic NK cells in macaques display antigen-specific memory responses to vaccination. This supports the notion of memory NK cells in primate liver, although the subset responsible has not yet been defined [11] .
Anatomical location and protein expression may also provide clues to function. CD49a + lrNK are found in the parenchyma and express cytotoxic effector molecules and receptors for MHC class I, so it seems likely that they recognise and kill virally infected or cancerous hepatocytes. Eomes hi lrNK, on the other hand, are found in the sinusoids and express fewer receptors for human targets, suggesting that they may recognise non-human cells in the blood. The liver processes blood coming from the gut, so the possibility that they may respond to bacteria or bacterial products is particularly attractive. In support of this hypothesis, mouse lrNK express high levels of AHR [3, 12] while Eomes hi lrNK in humans express IL23R and RORγt [9] and these genes are required for the development of ILC3, which are involved in the recognition of gut bacteria. Whatever the function of these cells, their frequency, longevity and conservation between mice and humans suggests that it is likely to be important and defining it will therefore represent a significant advance in our understanding of the hepatic immune system.
